Synthesis and biological evaluation of novel substituted 1,3,4-thiadiazole and 2,6-di aryl substituted imidazo [2,1-b] [1,3,4] thiadiazole derivatives
| dc.contributor.author | Chandrakantha, B. | |
| dc.contributor.author | Isloor, A.M. | |
| dc.contributor.author | Shetty, P. | |
| dc.contributor.author | Fun, H.-K. | |
| dc.contributor.author | Hegde, G. | |
| dc.date.accessioned | 2026-02-05T09:34:18Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | A new series of N-[5-(4-(alkyl/aryl)-3-nitro-phenyl)-[1,3,4-thiadiazol-2- yl]-2,2-dimethyl-propionamide 4 (a-l) and 6-(4-Methoxy-phenyl)-2-(4-alkyl/aryl)- 3-nitro-phenyl)-Imidazo [2,1-b] [1,3,4] thiadiazole 6 (a-l) were synthesized starting from 5-(4-Fluoro-3-nitro-phenyl)-[1,3,4] thiadiazole-2-ylamine. The synthesized compounds were characterized by IR, NMR, mass spectral and elemental analysis. All the compounds were tested for antibacterial and antifungal activities. The antimicrobial activities of the compounds were assessed by well plate method (zone of inhibition). Compounds 4a, 4c and 6e, 6g displayed appreciable activity at the concentration 0.5-1.0 mg/mL.© 2013 Elsevier Masson SAS. All rights reserved. | |
| dc.identifier.citation | European Journal of Medicinal Chemistry, 2014, 71, , pp. 316-323 | |
| dc.identifier.issn | 2235234 | |
| dc.identifier.uri | https://doi.org/10.1016/j.ejmech.2013.10.056 | |
| dc.identifier.uri | https://idr.nitk.ac.in/handle/123456789/26539 | |
| dc.publisher | Elsevier Masson s.r.l. | |
| dc.subject | (2,4 difluoro benzyl) [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl) 2 nitro phenyl) aminei | |
| dc.subject | (4 fluoro phenyl) [4 [6(4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl] amine | |
| dc.subject | 2,2 dimethyl n (5 [3 nitro 4 [4 (4 trifluoromethyl phenyl) piperdin 1 yl] phenyl) [1,3,4] thiadiazol 2 yl) propionamide | |
| dc.subject | 2,2 dimethyl n (5 [3 nitro 4 [tetrahydro furan 2 ylmethyl) amino] phenyl] [1,3,4] thiadiazol 2 yl) propionamide | |
| dc.subject | 2,2 dimethyl n [5 (4 morpholin 4 yl 3 nitro phenyl) [1,3,4] thiadiazo 2 yl] propionamide | |
| dc.subject | 2,2 dimethyl n [5 [4 (4 methyl piperazin 1 yl) 3 nitro phenyl] [1,3,4]thiadiazol 2 yl) propionamide | |
| dc.subject | 6 (4 methoxy phenyl) 2 (3 nitro 4 pyrrolidin 1 yl phenyl) imidazo [2,1 b] [1,3,4] thiadiazol | |
| dc.subject | 6 (4 methoxy phenyl) 2 [3 nitro 4 [4 (4 trifluoromethyl phenyl) piperidine 1 yl] phenyl imidazo | |
| dc.subject | 6 (4 methoxy phenyl) 2 [4 (4 methyl piperazin 1 yl) 3 nitro phenyl] imidazo [2,1 b] [1,3,4] thiadiazole | |
| dc.subject | 6 (4 methoxy phenyl) 2 [4 morpholin 4 1 yl) 3 nitro phenyl] imidazo [2,1 b] [1,3,4 thiadiazole | |
| dc.subject | antifungal agent | |
| dc.subject | antiinfective agent | |
| dc.subject | butyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine | |
| dc.subject | cyclohexyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine | |
| dc.subject | cyclopentyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine | |
| dc.subject | diethyl [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) amine | |
| dc.subject | n [5 (3 nitro 4 pyrrolidin 1 yl phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | n [5 (4 butylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | n [5 (4 cyclohexylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | n [5 (4 cyclopentylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | n [5 (4 diethylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | n [5 (4 dimethylamino 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | n [5 [4 (2,4 di fluoro benzylamino) 3 nitro phenyl) [1,3,4] thiadiazol 2 yl] 2,2 dimethyl propionamide | |
| dc.subject | thiadiazole derivative | |
| dc.subject | unclassified drug | |
| dc.subject | [4 [6 (4 methoxy phenyl) imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) dimethyl amine | |
| dc.subject | [4 [6 (4 methoxy phenyl)imidazo [2,1 b] [1,3,4] thiadiazol 2 yl] 2 nitro phenyl) (tetrahydro furan 2 ylmethyl) amine | |
| dc.subject | antibacterial activity | |
| dc.subject | antifungal activity | |
| dc.subject | antimicrobial activity | |
| dc.subject | article | |
| dc.subject | Aspergillus flavus | |
| dc.subject | Bacillus subtilis | |
| dc.subject | Candida albicans | |
| dc.subject | carbon nuclear magnetic resonance | |
| dc.subject | Chrysosporium | |
| dc.subject | drug synthesis | |
| dc.subject | Escherichia coli | |
| dc.subject | fungal strain | |
| dc.subject | proton nuclear magnetic resonance | |
| dc.subject | Pseudomonas aeruginosa | |
| dc.subject | 1,3,4-Thiadiazole | |
| dc.subject | 2,6-Diaryl imidazo [2,1-b] [1,3,4] thiadiazole | |
| dc.subject | Antibacterial | |
| dc.subject | Antifungal activity | |
| dc.subject | Anti-Bacterial Agents | |
| dc.subject | Antifungal Agents | |
| dc.subject | Bacteria | |
| dc.subject | Bacterial Infections | |
| dc.subject | Fungi | |
| dc.subject | Humans | |
| dc.subject | Microbial Sensitivity Tests | |
| dc.subject | Mycoses | |
| dc.subject | Thiadiazoles | |
| dc.title | Synthesis and biological evaluation of novel substituted 1,3,4-thiadiazole and 2,6-di aryl substituted imidazo [2,1-b] [1,3,4] thiadiazole derivatives |
